Evidence for a single-step mechanism in the origin of hyperdiploid childhood acute lymphoblastic leukemia
✍ Scribed by Kajsa Paulsson; Helena Mörse; Thoas Fioretos; Mikael Behrendtz; Bodil Strömbeck; Bertil Johansson
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 175 KB
- Volume
- 44
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
High hyperdiploidy (>50 chromosomes) in childhood acute lymphoblastic leukemia (ALL) is characterized by nonrandom multiple trisomies and tetrasomies involving in particular chromosomes X, 4, 6, 8, 10, 14, 17, 18, and 21. This characteristic karyotypic pattern, the most common in pediatric ALL, may arise via a tetraploid state with subsequent loss of chromosomes, by sequential gains of chromosomes in consecutive cell divisions, or by simultaneous gain of chromosomes in a single mitosis. These alternatives may be distinguished by investigation of the allelic ratios of loci on the tetrasomic and disomic chromosomes. Previous studies of tetrasomy 21 and of the occurrence of uniparental disomies (UPDs) have suggested that the most likely mechanism is simultaneous gain. However, the other pathways have not been definitely excluded because complete analyses of all disomies and tetrasomies have never been performed. In the present study, we investigated 27 hyperdiploid ALLs by using 58 polymorphic microsatellite markers mapped to 23 of the 24 human chromosomes. Twenty‐six tetrasomies were analyzed (involving chromosomes X, 8, 10, 14, 18, and 21), and the frequency of UPDs was determined in 10 cases. In total, 200 chromosomes were studied. Equal allele dosage was observed in 24 of 26 tetrasomies, and only 7 UPDs were found. These data strongly suggest that hyperdiploidy in childhood ALL generally arises by a simultaneous gain of all additional chromosomes in a single abnormal mitosis. © 2005 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract HLA class I molecules serve the essential immunological function of presenting antigen to CD8+ T lymphocytes. Tumor cells may present tumor‐specific antigen to T cells via these molecules, but many tumors show a loss or down‐regulation of HLA class I expression and this may serve as an
## Purpose: To report the feasibility and results of a study based on the bfm-all. nhl/86 protocol for b-non-hodgin's lymphoma (nhl) and b-acute lymphoblastic leukemia (b-all) in argentina. design. prospective, single arm, non-randomized trial. ## Patients and methods: From august 1988 to decembe